CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 24 No. 13
INTEGRATIVE ONCOLOGY 

Integrative Oncology: Oleander (Nerium oleander)

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD | December 16, 2010
Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Nerium oleander is an evergreen shrub that is cultivated as an ornamental plant throughout the tropical and subtropical parts of the world. It is used in traditional medicine to treat hemorrhoids, ulcers, and leprosy, and as an abortifacient. Extracts of oleander are promoted as a cure for AIDS, congestive heart disease, and cancer. Preclinical data suggest anticancer properties, but human studies are lacking. Patients should not self-medicate because safety and efficacy of oleander are not known.

—Barrie Cassileth, PhD

ALSO KNOWN AS: Rose laurel, adelfa, rosenlorbeer, karavira.

SUMMARY: Nerium oleander, an evergreen shrub, is native to the Mediterranean regions of Africa and Europe. It has been cultivated as an ornamental plant throughout the tropical and subtropical parts of the world; it is used in traditional medicine to treat hemorrhoids, ulcers, and leprosy—and as an abortifacient.

All parts of the plant contain compounds called cardiac glycosides, which are known for their toxicity. However, while cardiac glycosides in high doses are toxic, optimal doses can be effective in treating heart conditions. Also, some of these compounds exhibit selective toxicity against tumor cells.

Extracts of oleander are promoted to treat cancer, AIDS, and congestive heart failure, and a few of these extracts are being investigated in clinical trials. There are no data yet on their efficacy. In vitro studies indicate that oleandrin, a cardiac glycoside extracted from the leaves of oleander, causes apoptosis in several cancer cell lines[1-3] and increases the sensitivity to radiotherapy of PC-3 human prostate cells.[4] Results from a phase I study showed that oleandrin can be administered at doses up to 1.2mL/m2/day intramuscularly with no dose limiting toxicities.[5] More research is warranted.

Putative mechanisms of action include improved cellular export of fibroblast growth factor-2 (FGF-2)[1], induction of the Fas gene in tumor cells leading to apoptosis,[6] formation of superoxide radicals that cause tumor cell injury via mitochondrial disruption,[7] and inhibition of interleukin-8, which mediates tumorigenesis.[8] Oleandrin is also claimed to have analgesic properties.[9]

ADVERSE REACTIONS/ CONTRAINDICATIONS: The leaves of Nerium oleander are toxic when consumed.[10] Onset of toxicity occurs several hours following consumption; symptoms can include vomiting, abdominal pain, cyanosis, hypotension, hypothermia, vertigo, respiratory paralysis, and death.[11] Consumption of oleander leaves resulted in the death of an adult diabetic male.[12]

Patients with hypercalcemia, hypokalemia, bradycardia, ventricular tachycardia, or heart failure should not use this product.[11]

HERB/DRUG INTERACTIONS: It has been hypothesized that the cardiac glycosides in Nerium oleander may have an additive effect with digoxin(Drug information on digoxin), resulting in toxicity.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES
1. Smith JA, Madden T, Vijjeswarapu M, et al. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem Pharmacol. 2001;62:469-72.
2. Manna SK, Sah NK, Newman RA, et al. Oleandrin suppresses activation of nuclear transcription factor-kB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res. 2000;60:3838-47.
3. Pathak S, Multani AS, Narayan S, et al. Anvirzel™, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs. 2000;11:455-63.
4. Nasu S, Milas L, Kawabe S, et al. Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process. Cancer Lett. 2002;185:145-51.
5. Mekhail T, Kellackey C, Hutson T, et al. Phase I Study of Anvirzel in patients with advanced solid tumors. Am Soc Clin Oncol. 2001;20:826.
6. Sreenivasan Y, Raghavendra PB, Manna SK. Oleandrin-mediated expression of fas potentiates apoptosis in tumor cells. J Clin Immunol. 2006;26:308-22.
7. Mcconkey DJ, Lin Y, Nutt LK, et al. Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res. 2000;60:3807-12.
8. Newman RA, Yang P, Hittelman WN, et al. Oleandrin-mediated oxidative stress in human melanoma cells. J Exp Ther Oncol. 2006;5:167-81.
9. Ozel HZ. Extracts of Nerium species, methods of preparation, and use therefore. US Patent #5,135,745. August 4, 1992.
10. Ada SE, Al-Yahya MA, Al-Farhan AH. Acute toxicity of various oral doses of dried Nerium oleander leaves in sheep. Am J Chin Med. 2001;29:525-32.
11. Schulz V, Hansel R, Tyler V. Rational phytotherapy: a physician’s guide to herbal medicine. 4th ed. New York: Springer; 2001.
12. Wasfi IA, Zorob O, Al Katheeri NA, Al Awadhi AM. A fatal case of oleandrin poisoning. Forensic Sci Int. 2008;179:e31-6.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy